Voyager Therapeutics, Inc. (VYGR)
NASDAQ·Healthcare·Biotechnology
$3.80
+0.93%
Mkt Cap $224.09M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $10.49M | $15.34M | +46.17% | -$0.54 | -$0.46 | +14.81% | — | — |
| Q4 2025 Nov 10, 2025 | $10.49M | $13.37M | +27.38% | -$0.53 | -$0.47 | +11.32% | — | — |
| Q3 2025 Aug 6, 2025 | $7.86M | $5.20M | -33.83% | -$0.48 | -$0.57 | -18.75% | — | — |
| Q2 2025 May 6, 2025 | $13.91M | $6.47M | -53.45% | -$0.35 | -$0.53 | -51.43% | — | — |
| Q1 2025 Mar 11, 2025 | $12.95M | $6.28M | -51.51% | -$0.35 | -$0.59 | -68.57% | — | — |
| Q4 2024 Nov 12, 2024 | $15.46M | $24.63M | +59.35% | -$0.45 | -$0.16 | +64.44% | — | — |
| Q3 2024 Aug 6, 2024 | $9.46M | $29.58M | +212.66% | -$0.38 | -$0.18 | +52.63% | — | — |
| Q2 2024 May 13, 2024 | $9.41M | $19.52M | +107.40% | -$0.44 | -$0.20 | +54.55% | — | — |
| Q1 2024 Feb 28, 2024 | $20.63M | $90.06M | +336.55% | -$0.29 | $1.25 | +531.03% | — | — |
| Q4 2023 Nov 6, 2023 | $5.56M | $4.61M | -17.01% | -$0.58 | -$0.59 | -1.72% | — | — |
| Q3 2023 Aug 3, 2023 | $1.77M | $4.85M | +174.18% | -$0.59 | -$0.51 | +13.56% | — | — |
| Q2 2023 May 9, 2023 | $61.11M | $150.48M | +146.24% | $0.77 | $2.94 | +281.82% | — | — |
| Q1 2023 Mar 7, 2023 | $4.19M | $41.09M | +880.60% | -$0.57 | -$0.61 | -7.02% | — | — |
| Q4 2022 Nov 8, 2022 | $9.42M | $41.09M | +336.34% | -$0.32 | $0.45 | +240.63% | — | — |
| Q3 2022 Aug 4, 2022 | $7.03M | $712.00K | -89.87% | -$0.56 | -$0.50 | +10.71% | — | — |
| Q2 2022 May 4, 2022 | $12.71M | $658.00K | -94.82% | -$0.14 | -$0.56 | -300.00% | — | — |
| Q1 2022 Mar 8, 2022 | $4.30M | $28.07M | +553.41% | -$0.32 | $0.15 | +146.87% | — | — |
| Q4 2021 Nov 2, 2021 | $1.84M | $1.48M | -19.46% | -$0.75 | -$0.67 | +10.67% | — | — |
| Q3 2021 Aug 9, 2021 | $1.36M | $1.36M | +0.00% | -$0.75 | -$0.80 | -6.67% | — | — |
| Q2 2021 May 10, 2021 | $7.29M | $6.50M | -10.81% | -$0.71 | -$0.58 | +18.31% | — | — |